Literature DB >> 7909090

Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients.

C R Harrington1, C M Wischik, F K McArthur, G A Taylor, J A Edwardson, J M Candy.   

Abstract

Tau protein is a major structural protein of the paired helical filaments (PHFs) found in both neuritic senile plaques and neurofibrillary tangles in Alzheimer's disease (AD). Senile plaques also contain amyloid beta protein (A beta). We did an immunochemical analysis of frontal cortex from 15 dialysis cases, 5 Alzheimer's disease patients, and 6 control cases to see whether AD-like changes in A beta deposition and tau protein were linked to aluminium accumulation. Dialysis patients were used because they are frequently exposed to increased levels of aluminium. 8 of the 15 dialysis cases had insoluble A beta, but there was no association between its presence and the accumulation of aluminium. However, we found AD-like changes in the processing of tau protein. In white matter, truncated tau protein in the PHF-core fraction and endogenously truncated tau in the supernatant fraction were both increased in association with aluminium accumulation in the brain. In grey matter, normal tau protein was depleted and insoluble hyperphosphorylated tau increased in association with aluminium concentration. Protease-resistant PHFs were present in grey matter in 2 dialysis cases, a frequency above that expected for AD in this age group. PHF-core tau in both grey and white matter correlated with decreased levels of normal tau protein in white matter. These findings are consistent with a role for aluminium in the development of AD-like pathology in patients subjected to prolonged aluminium exposure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7909090     DOI: 10.1016/s0140-6736(94)90124-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

2.  Aluminum stimulates uptake of non-transferrin bound iron and transferrin bound iron in human glial cells.

Authors:  Yongbae Kim; Luisa Olivi; Jae Hoon Cheong; Alex Maertens; Joseph P Bressler
Journal:  Toxicol Appl Pharmacol       Date:  2007-02-09       Impact factor: 4.219

3.  A Profile of Nanoparticle-Based Plasma Neurodegenerative Biomarkers for Cognitive Function Among Patients Undergoing Hemodialysis.

Authors:  Jin-Bor Chen; Chiung-Chih Chang; Sin-Hua Moi; Lung-Chih Li
Journal:  Int J Gen Med       Date:  2022-07-11

4.  Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.

Authors:  C M Wischik; P C Edwards; R Y Lai; M Roth; C R Harrington
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

5.  A human ubiquitin conjugating enzyme, L-UBC, maps in the Alzheimer's disease locus on chromosome 14q24.3.

Authors:  P A Robinson; J P Leek; J Thompson; I M Carr; A Bailey; T P Moynihan; P L Coletta; N J Lench; A F Markham
Journal:  Mamm Genome       Date:  1995-10       Impact factor: 2.957

Review 6.  Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.

Authors:  C A Shaw; L Tomljenovic
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

7.  Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle.

Authors:  S Colafrancesco; N Agmon-Levin; C Perricone; Y Shoenfeld
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

8.  Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses.

Authors:  Masahiro Kawahara; Midori Kato-Negishi
Journal:  Int J Alzheimers Dis       Date:  2011-03-08

9.  Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment.

Authors:  J R Walton
Journal:  Int J Alzheimers Dis       Date:  2012-07-30

Review 10.  Metals and Neurodegeneration.

Authors:  Pan Chen; Mahfuzur Rahman Miah; Michael Aschner
Journal:  F1000Res       Date:  2016-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.